The World Health Organization is looking at ways to improve, and speed up, the approval of variations applications submitted under its pre-qualification programme that facilitates access to medicines meeting unified standards of quality, safety and efficacy of medicines1...
Scrip Regulatory Affairs
WHO aims for faster approval of variations to pre-qualified products
16 April 2010
Vibha Sharma
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- Canada consults on proposed changes to clinical trials guideline for drugs
- ICH to clarify E3 guideline on clinical study reports and alignment with CTD
- Danish agency updates guidelines on different submission formats
- Higher US generic drugs user fee for foreign units 'discriminatory, anti-competitive', say Indian firms
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
